Sort
11,323 grants matching “glioblastoma”
A 3D ex vivo orthotopic xenograft screening platform to identify radiosensitization targets and druggability in glioma
$175,088Scott R Floyd · Duke University · R21 · FY2020 · CA
Carbon Nanotube-based Microbeam Radiation Therapy for Human Brain Cancer
$175,037Otto Z Zhou · Univ Of North Carolina Chapel Hill · U54 · FY2013 · CA
Pre-Clinical Vector Production Core
$175,034William F. Goins · Ohio State University · P01 · FY2016 · CA
Targeted Modulation of the Death Receptor as a Therapeutic Strategy for Glioma
$174,992Jay Fitzgerald Dorsey · University Of Pennsylvania · K08 · FY2011 · NS
Intra-tumor Heterogeneity in Colorectal Cancer Progression and Treatment Response
$174,960Karin Marie Hardiman · University Of Michigan At Ann Arbor · K08 · FY2016 · CA
Intra-tumor Heterogeneity in Colorectal Cancer Progression and Treatment Response
$174,960Karin Marie Hardiman · University Of Michigan At Ann Arbor · K08 · FY2017 · CA
Intra-tumor Heterogeneity in Colorectal Cancer Progression and Treatment Response
$174,960Karin Marie Hardiman · University Of Alabama At Birmingham · K08 · FY2019 · CA
Pilot Project 1: Combination of Viroimmunotherapy and Microbiota Modulation to Treat Gastric Cancer
$174,927Filipa Godoy-Vitorino · University Of Puerto Rico Med Sciences · U54 · FY2021 · CA
Mixed-Ligand Targeting of a Nano-Pharmaceutical Against GBM Stem Cells
$174,766Steven L Armentrout · Parabon Nanolabs, Inc. · U43 · FY2011 · CA
Image Guided Genome-Epigenome Analysis of Tumor Heterogeneity and Evolution
$174,741Joseph F Costello · University Of California, San Francisco · P01 · FY2017 · CA
Identifying the biosynthesis of a potent cytotoxic agent Lasonolide A
$174,728Guojun Wang · Florida Atlantic University · R21 · FY2017 · CA
STTR Phase I: High throughput aligned nanofiber multiwell plates for glioblastoma research
$174,608Jed K Johnson · Nanofiber Solutions · · FY2010 · TIP
Mass Spectrometry, Proteomics and Metabolomics Core
$174,560John M Asara · Brigham And Women'S Hospital · P01 · FY2015 · CA
The Role of Eph-ephrin Interactions in Glioma Migration
$174,533Columbia University Health Sciences · K08 · FY2005 · NS
MDM2 inhibitor therapy for TP53 wild-type GBM
$174,365Jann N Sarkaria · Mayo Clinic Rochester · U19 · FY2024 · CA
Core 1: Biospecimen and Pathology Core
$174,228William H. Yong · University Of California Los Angeles · P50 · FY2019 · CA
Core 1: Biospecimen and Pathology Core
$174,226Fausto Rodriguez · University Of California Los Angeles · P50 · FY2021 · CA
Development of single cell magnetophoresis to analyze and isolate glioma cancer stem cells
$174,204Jeffrey John Chalmers · Ohio State University · R21 · FY2020 · CA
Toward Changing Glioblastoma Outcomes: Targeted drug delivery of an inhibitory biopolymer in conjunction with systemic chemotherapy
$174,129Drazen Raucher · University Of Mississippi Med Ctr · R21 · FY2020 · CA
Mechanism of regulation of progenitor proliferation and transformation
$174,117Patrizia Casaccia · Advanced Science Research Center · R01 · FY2019 · NS
Mechanism of regulation of progenitor proliferation and transformation
$174,032Patrizia Casaccia · Advanced Science Research Center · R01 · FY2020 · NS
In situ assay imaging nuclear RNA exosome activity for cancer studies
$174,000Vladimir V Didenko · Baylor College Of Medicine · R21 · FY2021 · CA
Pilot randomized neoadjuvant vaccine with CD27-costimulation in low-grade glioma
$173,962Hideho Okada · University Of California, San Francisco · R21 · FY2020 · CA
Engineering a multispecific receptor antagonist to inhibit cancer metastasis
$173,934Jennifer R Cochran · Stanford University · R21 · FY2015 · CA
An engineered oncolytic herpes virus expressing a full-length α-CD47 mAb for the treatment of GBM
$173,914Jianhua Yu · Beckman Research Institute/City Of Hope · U19 · FY2021 · CA